Oral Laquinimod for Multiple Sclerosis Passes Phase 3 Extension
March 21, 2013 Teva Pharmaceutical and Active Biotech announced top-line results from an open-label extension of the Phase 3 ALLEGRO study,…
Biogen’s Tecfidera multiple sclerosis drug wins EU agency backing
Published: March 22, 2013 By Meg Tirrell — Bloomberg News Biogen Idec, maker of the multiple sclerosis drugs Avonex and Tysabri,…
Stuart Schlossman
US Patent Office grants Biogen Idec broad protection for multiple sclerosis pill
March 19, 2013 By Robert Weisman, Globe Staff Federal officials Tuesday gave Biogen Idec Inc. 15-year patent protection for its…
Stuart Schlossman
BG-12 (Biogen’s Oral) NOW has a Name: TECFIDERA
Tecfidera (BG-12) awaits FDA decision .. January 31, 2013 Tecfidera (BG-12) is pending FDA decision on March 27, 2013. This…
Stuart Schlossman
Highlands (of Scotland) first for MS treatment
By HILARY DUNCANSON Published on Saturday 5 January 2013 MULTIPLE sclerosis patients in the Highlands are the first in Scotland to…
Stuart Schlossman
Ocala Florida – February 16, 2013 – Treatment Strategies, MS Relapse information and Therapeutic Symptom Management in Multiple Sclerosis
The MS Views and News organization invites you to an informative MS education program Treatment Strategies, MS Relapse information and…
Stuart Schlossman
Genzyme multiple sclerosis medication wins approval in Australia
November 22, 2012 Australian Therapeutic Goods Administration (TGA) has cleared Genzyme’s once daily oral Aubagio 14mg dose for the treatment…
Stuart Schlossman
When to Tell Loved Ones You Have Multiple Sclerosis (Includes urologic & sexual content, equestrian therapy, Statins, BG-12 and more)
Whether you’re talking about MS with close relatives, friends, or someone you just started dating, these tips will help you…
Stuart Schlossman
The New England Journal of Medicine Publishes Pivotal Data Demonstrating Efficacy and Safety of Oral
The New England Journal of Medicine Publishes Pivotal Data Demonstrating Efficacy and Safety of Oral BG-12 (Dimethyl Fumarate) in Multiple…
Stuart Schlossman
Positive Data on Sanofi’s Aubagio – Analyst Blog
October 24, 2012 Sanofi ( SNY ) and its subsidiary Genzyme recently presented positive data on its oral treatment for relapsing forms of…
Stuart Schlossman
